A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients

Asian Journal of Andrology

Volumn 2, Issue 4, 2000, Pages 301-303

  Fu, Qiang ^a   Yao, De Hong ^a   Jiang, Yue Qin ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Erectile dysfunction; Intracavernous injection; Nitric oxide; Sodium nitroprusside

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PAPAVERINE; PHENTOLAMINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG COMBINATION; DRUG EFFECT; HUMAN; IMPOTENCE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PENIS; PENIS ERECTION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VASCULARIZATION;

ADULT; AGED; DRUG ADMINISTRATION ROUTES; DRUG THERAPY, COMBINATION; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PAPAVERINE; PENILE ERECTION; PENIS; PHENTOLAMINE;

EID: 0034566171     PISSN: 1008682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jonas WF, editor. Erectile dysfunction. Berlin; Springer-Verlag; 1991. p 223-8.
2. Brindley GS. Cavernosal alpha-blockade; a new technique for investigating and treating erectile impotence. Br J Psychiacry 1983; 143; 332-8.
3. Ishii N, Watanabe H, Irisawa C, Kikuchi Y, Kubota Y, Kawamura S, et al. Intracavernous injection of prostaglandin E, for the treatment of erectile impotence. J Urol 1989; 141: 323-9.
4. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326; 90-4.
5. Jeremy JY, Ballard SA, Naylor AM, Miller MA, Angelini GD. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br J Urol 1997; 79: 958-63.
6. Azadzoi KM, Goldstein I, Siroky MB, Traish AM, Krane RJ, Saenz de Tejada I. Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol 1998; 160 (6 Pt 1): 2216-22.
7. Virag R, Erydman D, Legman M, Virag H. Intracavernous injection of papaverine as a diagnosis and therapeutic method in erectile failure. Angiology 1984; 35: 79-84.
8. Willis EA, Ottesen B, Wagner G, Sundler F, Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) as a possible neurotansmitter involved in penile erection. Acta Physiol Scand 1981; 113: 545-9.
9. Hedlund H, Andersson KE. Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery. J Urol 1985; 134: 1245-51.
10. Stief CG, Benard F, Bosch RJ, Aboseif SR, Lue TF, Tanagho EA. A possible role for calcitonin-gene-related peptide in the regulation of the smooth muscle tone of the bladder and penis. J Urol 1990; 143: 392-8.
11. Chuang AT, Strauss JD, Murphy RA, Steers WD. Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J Urol 1998; 160: 257-61.
12. Kim N, Azadzoi KM, Goldstein I, Saenz de Tejada I. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenicrelaxation of penile corpus cavernosum smooth muscle. J Clin Invest 1991; 88: 112-8.
13. Haas CA, Seftel AD, Razmjouei K, Ganz MB, Hampel N, Ferguson K. Erectile dysfunction in aging; upregulation of endothelial nitric oxide synthase. Urology 1998; 51: 516-22.
14. 1 in patients with erectile dysfunction. J Urol 1995; 153: 1487-92.
15. Brock G, Breza J, Lue TF. Intracavernous sodium nitroprusside; inappropriate impotence treatment. J Urol 1993; 150; 864-67.
16. 1 in patients with erectile dysfunction. Eur Urol 1998; 34: 350-4.
17. Tarhan F, Kuyumcuoglu U, Kolsuz A, Ozgul A, Canguven O. Effect of intracavernosal sodium nitroprusside in impotence. Urol Int 1996; 56: 211-4.